You searched for prescription-drugs | Page 17 of 180

As COVID-19 Divisions, Attacks, and Misinformation Take Their Toll, Less Than Half of the Public Is Confident That the CDC and FDA Can Carry Out Core Functions

May 6, 2025

News Release

Five years after the start of COVID-19 pandemic and the communications challenges, divisions, and false claims that followed, less than half of the public say they have at least some confidence in the federal government’s health agencies like the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) to carry out many of their core responsibilities, a new KFF Tracking Poll on Health Information and Trust finds.The low levels of…

I’m receiving extra help with my Part D plan premium and cost sharing through the Low-income Subsidy Program. I received a notice that my current plan will no longer be offered next year. Now what do I do?

Oct 9, 2026

FAQs

If you qualify for extra help with your Medicare prescription drug costs, are enrolled in traditional Medicare, and your current prescription drug plan will not be offered next year, you will be automatically reassigned by Medicare to a new prescription drug plan for coverage in the next year. But you won’t be reassigned automatically if your current plan is terminating and you chose your current plan. In that case, you will have to enroll in…

2025 California Health Benefits Survey

Nov 18, 2025

Report

The survey provides an in-depth look at trends in employer-sponsored coverage in California, including premiums, cost sharing, offer rates, and employer strategies to manage costs and access to care, including comparisons to the nation overall.

Five Key Facts About Spending and Enrollment for People with Medicare and Medicaid (Dual-Eligible Individuals)

Jul 15, 2026

Issue Brief

This issue brief analyzes provides a profile of enrollment and spending on dual-eligible individuals, drawing on new analysis of data on chronic conditions to show how higher rates of chronic conditions contribute to higher average spending among this population.

What Newly Released Medicaid Data Do and Don’t Tell Us

Feb 20, 2026

Policy Watch

On February 14, 2026, CMS released a dataset with provider-level spending data that the agency suggests could be used to identify unusual billing patterns for specific services, states, or providers. This policy watch describes what the data include, what they exclude, and how they could potentially lead to mistaken conclusions given the limitations of the data.

Vice President Harris’ Proposal to Broaden Medicare Coverage of Home Care

Oct 11, 2024

Issue Brief

On October 8, 2024, Vice President Harris has proposed to expand Medicare to provide home care to help families who are struggling with the costs of long-term care. If enacted, this would be the first major expansion of Medicare since the Medicare Modernization Act of 2003 that added a prescription drug benefit to the program.

Unpacking the Prescription Drug Provisions of the Build Back Better Act

Event Date: Dec 8, 2021

Event

As the Build Back Better Act shifts from the House to the Senate, there’s considerable interest in provisions that would lower the cost of prescription drugs. The House-passed bill would allow the federal government to negotiate prices for some high-cost drugs in Medicare, and set a hard cap on out-of-pocket drug spending for Medicare Part D enrollees. For people with Medicare and private insurance, the legislation would limit annual increases in drug prices and cap…

Costs and Other Barriers to Care Can Worsen Health For Adults With Multiple or Complex Health Conditions

Health Care Access and Affordability for Adults with Multiple or Complex Health Conditions: A Snapshot of Patient Experiences

Sep 15, 2026

Poll Finding

Significant shares of adults with multiple or complex health conditions, including cancer, lung disease, diabetes, cardiovascular disease, and mental health conditions say they struggle to pay their medical bills and access needed care and medication. These challenges fall hardest on uninsured adults who face greater costs and access challenges.

In his latest column, KFF’s President and CEO Drew Altman discusses how the low levels of trust in the CDC and FDA today seen in KFF’s recent survey findings present a danger should the country face another epidemic.

The Sad State of Trust in the CDC and FDA

May 7, 2025

From Drew Altman

In his latest column, KFF’s President and CEO Drew Altman discusses how the low levels of trust in the CDC and FDA today seen in KFF’s recent survey findings present a danger should the country face another epidemic.

Summary of Costs and Impact of the Prescription Drug Provisions in the Build Back Better Act

Nov 23, 2021

News Release

As the House-passed Build Back Better Act moves to the Senate, a new explainer from KFF summarizes the key prescription drug provisions within the broader budget reconciliation bill. These provisions would lower prescription drug costs paid by people with Medicare and private insurance and curb drug spending by the federal government and private payers. The Congressional Budget Office estimates federal budget savings from the drug pricing provisions would be $297 billion over 10 years. Although…

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter